World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
23501
World Ranking
13337
National Ranking
6784

David M. Parham publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David M. Parham sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 397 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

David M. Parham D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David M. Parham sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 88 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

David M. Parham is affiliated with the Children's Hospital of Los Angeles in the United States. Their research contributions focus primarily on medical and clinical studies related to pediatric oncology and pathology.

The main field of study for David M. Parham is Medicine, with a particular emphasis on subfields such as Pulmonary and Respiratory Medicine, Surgery, Molecular Biology, Oncology, and Rheumatology.

The primary topics covered in their work include:

  • Sarcoma Diagnosis and Treatment
  • Testicular diseases and treatments
  • Tumors and Oncological Cases
  • Soft tissue tumor case studies
  • Congenital Diaphragmatic Hernia Studies
  • Renal and related cancers
  • CAR-T cell therapy research

David M. Parham has published frequently in the following venues:

  • Pediatric and Developmental Pathology
  • Pediatric Blood & Cancer
  • European Journal of Cancer
  • Archives of Pathology & Laboratory Medicine
  • Scientific Reports

Recent papers by David M. Parham include:

  • Transcriptome analysis of desmoplastic small round cell tumors identifies actionable therapeutic targets: a report from the Children's Oncology Group (2020, Scientific Reports)
  • Alveolar rhabdomyosarcoma with regional nodal involvement: Results of a combined analysis from two cooperative groups (2020, Pediatric Blood & Cancer)
  • The prognostic significance of anaplasia in childhood rhabdomyosarcoma: A report from the Children's Oncology Group (2020, European Journal of Cancer)
  • Rhabdomyosarcoma: How Advanced Molecular Methods Are Shaping the Diagnostic and Therapeutic Paradigm (2021, Pediatric and Developmental Pathology)
  • Histopathologic features of alveolar capillary dysplasia with misalignment of pulmonary veins with atypical clinical presentation (2020, Cardiovascular Pathology)

Frequent coauthors collaborating with David M. Parham include:

  • Erin R. Rudzinski
  • Larry Wang
  • Douglas S. Hawkins
  • Nick Shillingford
  • Shengmei Zhou

Best Publications

  • Severe Acquired Immunodeficiency in Male Homosexuals, Manifested by Chronic Perianal Ulcerative Herpes Simplex Lesions

    F P Siegal;C Lopez;G S Hammer;A E Brown

  • Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification‐an intergroup rhabdomyosarcoma study

    William A. Newton;Edmund A. Gehan;Bruce L Webber;Henry B. Marsden

  • Prognostic Factors and Clinical Outcomes in Children and Adolescents With Metastatic Rhabdomyosarcoma—A Report From the Intergroup Rhabdomyosarcoma Study IV

    John C. Breneman;Elizabeth Lyden;Alberto S. Pappo;Michael P. Link

  • The clinicopathologic spectrum of putative extrarenal rhabdoid tumors. An analysis of 42 cases studied with immunohistochemistry or electron microscopy.

    D M Parham;D A Weeks;J B Beckwith

  • Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803.

    Carola A.S. Arndt;Julie A. Stoner;Douglas S. Hawkins;David A. Rodeberg

  • Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor.

    Andrew L. Folpe;Charles E. Hill;David M. Parham;Patricia A. O'shea

  • A specific chromosomal abnormality in rhabdomyosarcoma

    Edwin C. Douglass;M. Valentine;E. Etcubanas;D. Parham

  • Rhabdomyosarcomas in adults and children: an update.

    David M. Parham;Dale A. Ellison

  • Classification of rhabdomyosarcoma and its molecular basis.

    David M. Parham;Frederic G. Barr

  • Survival After Relapse in Children and Adolescents With Rhabdomyosarcoma: A Report From the Intergroup Rhabdomyosarcoma Study Group

    Alberto S. Pappo;James R. Anderson;William M. Crist;Moody D. Wharam

  • The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS-I Through IRS-IV Studies as Background for the Current IRS-V Treatment Protocols.

    R. Beverly Raney;Harold M. Maurer;James R. Anderson;Richard J. Andrassy

  • Pathologic Classification of Rhabdomyosarcomas and Correlations with Molecular Studies

    David M Parham

  • PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: A children's oncology group report

    Stephen X. Skapek;James Anderson;Frederic G. Barr;Julia A. Bridge

  • Intergroup Rhabdomyosarcoma Study: Update for Pathologists:

    Stephen J. Qualman;Cheryl M. Coffin;William A. Newton;Hiroshi Hojo

  • Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

    D. Joshi;James R. Anderson;C. Paidas;J. Breneman

  • MR imaging differentiation of benign and malignant peripheral nerve sheath tumors: use of the target sign

    Ravi Bhargava;David M. Parham;David M. Parham;Olga E. Lasater;Radha S. Chari

  • An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children's Oncology Group experience.

    Raffaella A. Morotti;Kathleen K. Nicol;David M. Parham;Lisa A. Teot

  • Therapy for localized Ewing's sarcoma of bone

    F A Hayes;E I Thompson;W H Meyer;L Kun

  • Primary malignant neuroepithelial tumors of the kidney: a clinicopathologic analysis of 146 adult and pediatric cases from the National Wilms' Tumor Study Group Pathology Center.

    David M. Parham;Gary J. Roloson;Michael Feely;Daniel M. Green;Daniel M. Green

  • Rhabdomyosarcoma. A new classification scheme related to prognosis.

    Tsokos M;Webber Bl;Parham Dm;Wesley Ra

Frequent Co-Authors

Alberto S. Pappo
Alberto S. Pappo St. Jude Children's Research Hospital
Charles B. Pratt
Charles B. Pratt St. Jude Children's Research Hospital
Sarah S. Donaldson
Sarah S. Donaldson Stanford University
Timothy J. Triche
Timothy J. Triche Van Andel Institute
Suzanne L. Wolden
Suzanne L. Wolden Memorial Sloan Kettering Cancer Center
Julia A. Bridge
Julia A. Bridge University of Nebraska Medical Center
Peter J. Houghton
Peter J. Houghton The University of Texas Health Science Center at San Antonio
Julie M. Gastier-Foster
Julie M. Gastier-Foster Baylor College of Medicine
Jaclyn A. Biegel
Jaclyn A. Biegel University of Southern California
Cornelius F. Boerkoel
Cornelius F. Boerkoel University of British Columbia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine opens the door to many alternative degrees and professional tracks. Many students are interested in flexible educational paths that allow for a balance between work, study, and family commitments. For registered nurses seeking career advancement, adn to fnp programs offer a streamlined route to becoming a Family Nurse Practitioner through online bridge courses.

Beyond clinical roles, allied health and administrative pathways are also growing. For example, those passionate about wellness may consider a nutrition degree online, which provides foundational knowledge for roles in healthcare, fitness, and research.

Leadership and management in healthcare is another promising avenue. Accredited online options such as the best mha programs can prepare you for executive roles in hospital and healthcare systems.

For nurses looking to earn a bachelor’s degree without the need for onsite training, best online rn to bsn programs without clinical requirements provide a valuable, flexible credential. Each of these online degree options offers a tailored route towards rewarding roles in the evolving healthcare landscape.

Best Scientists Citing David M. Parham

Trending Scientists

Recently Published Articles